Int J Med Sci 2020; 17(8):985-994. doi:10.7150/ijms.42561 This issue Cite

Research Paper

The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction

Małgorzata Peregud-Pogorzelska1*, Krzysztof Przybycień1*, Bartłomiej Baumert2, Maciej Kotowski2, Ewa Pius-Sadowska2, Krzysztof Safranow3, Jarosław Peregud-Pogorzelski4, Zdzisława Kornacewicz-Jach1, Edyta Paczkowska2✉, Bogusław Machaliński2✉

1. Department of Cardiology, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland
2. Department of General Pathology, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland
3. Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland
4. Department of Paediatric Oncology, Pomeranian Medical University, Unii Lub. 1, 71-252 Szczecin, Poland
* Authors contributed equally to this work

Citation:
Peregud-Pogorzelska M, Przybycień K, Baumert B, Kotowski M, Pius-Sadowska E, Safranow K, Peregud-Pogorzelski J, Kornacewicz-Jach Z, Paczkowska E, Machaliński B. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction. Int J Med Sci 2020; 17(8):985-994. doi:10.7150/ijms.42561. https://www.medsci.org/v17p0985.htm
Other styles

File import instruction

Abstract

Introduction: Regenerative capacity of the heart is limited, and the post-infarct left ventricle (LV) dysfunction is associated with poor prognosis. Administration of stem/progenitor cells (SPCs) is a promising approach for cardiac regeneration.

Objectives: In the study, we assessed LV function and post-infarcted remodeling in patients with ST-elevated myocardial infarct (STEMI) who received autologous lineage-negative (LIN-) SPCs.

Patients and methods: Patients with STEMI and one-vessel coronary artery disease treated with percutaneous revascularisation were divided into study group (LIN- group, 15 patients) that received standard therapy and autologous BM-derived LIN- SPCs and control group (standard therapy group, 19 patients). The cells were administered intracoronary 24 hours after STEMI. The follow-up was 12 months with subsequent non-invasive tests and laboratory parameter evaluation on days 1st, 3rd, and 7th as well as at 1st, 3rd, 6th and 12th month after STEMI.

Results: All procedures related to SPCs administration were well tolerated by the patients. In 12-month follow-up, there were no major adverse cardiac events connected with LIN- SPCs administration. During 12-month follow-up, 9 patients from LIN- group (Responders) achieved an improvement in LV ejection fraction (>10% after 12 months) with no signs of unfavorable LV remodeling. Laboratory parameters analysis showed that Troponin T levels were significantly lower until day 7th in the Responders group, while brain natriuretic peptide (BNP) level remained significantly lower from day 3rd to 12th month respectively.

Conclusions: Intracoronary infusion of autologous BM-derived LIN- stem/progenitor cells is feasible and safe for patient. Improvement in LV function and prevention of unfavorable remodeling in the 60% of study group seems relatively promising. Stem cell-based therapy for cardiac regeneration still needs more accurate and extensive investigations to estimate and improve their efficacy.

Keywords: infarct, left ventricular failure, lineage-negative cells, remodeling, stem/progenitor cells


Citation styles

APA
Peregud-Pogorzelska, M., Przybycień, K., Baumert, B., Kotowski, M., Pius-Sadowska, E., Safranow, K., Peregud-Pogorzelski, J., Kornacewicz-Jach, Z., Paczkowska, E., Machaliński, B. (2020). The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction. International Journal of Medical Sciences, 17(8), 985-994. https://doi.org/10.7150/ijms.42561.

ACS
Peregud-Pogorzelska, M.; Przybycień, K.; Baumert, B.; Kotowski, M.; Pius-Sadowska, E.; Safranow, K.; Peregud-Pogorzelski, J.; Kornacewicz-Jach, Z.; Paczkowska, E.; Machaliński, B. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction. Int. J. Med. Sci. 2020, 17 (8), 985-994. DOI: 10.7150/ijms.42561.

NLM
Peregud-Pogorzelska M, Przybycień K, Baumert B, Kotowski M, Pius-Sadowska E, Safranow K, Peregud-Pogorzelski J, Kornacewicz-Jach Z, Paczkowska E, Machaliński B. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction. Int J Med Sci 2020; 17(8):985-994. doi:10.7150/ijms.42561. https://www.medsci.org/v17p0985.htm

CSE
Peregud-Pogorzelska M, Przybycień K, Baumert B, Kotowski M, Pius-Sadowska E, Safranow K, Peregud-Pogorzelski J, Kornacewicz-Jach Z, Paczkowska E, Machaliński B. 2020. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction. Int J Med Sci. 17(8):985-994.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.